Evidence map›Paper›PMID 38081823›Full record

ArticleNature communications2023

Deep learning of cell spatial organizations identifies clinically relevant insights in tissue images.

Shidan Wang, Ruichen Rong, Qin Zhou, Donghan M Yang, Xinyi Zhang, Xiaowei Zhan, Justin Bishop, Zhikai Chi, Clare J Wilhelm, Siyuan Zhang and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Leveraging AI for cell biology discovery.Biochemical Society transactions · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Shidan WangQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA. Shidan.Wang@utsouthwestern.edu.ORCID 0000-0002-0001-3261
Ruichen RongQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Qin ZhouQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-7269-1731
Donghan M YangQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Xinyi ZhangQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-7175-426X
Xiaowei ZhanQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Justin BishopDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Zhikai ChiDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-3601-3351
Clare J WilhelmDepartment of Thoracic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Siyuan ZhangDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0003-0910-3666
Curtis R PickeringDepartment of Surgery, Yale School of Medicine, New Haven, CT, USA.
Mark G KrisDepartment of Thoracic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
John MinnaHamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-7776-0767
Yang XieQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Guanghua XiaoQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA. Guanghua.Xiao@utsouthwestern.edu.ORCID 0000-0001-9387-9883

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GIBBONS, DON LYNN · 1996 to 2024
$57.4M
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant DisordersR01DE030656 · NIDCR · YALE UNIVERSITY · PI PICKERING, CURTIS, XIAO, GUANGHUA · 2021 to 2025
$3.4M
Novel computational approaches to predict drug response and combination effectsR35GM136375 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI XIE, YANG · 2020 to 2024
$2.0M
Developing computational algorithms for histopathological image analysisR01GM140012 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI XIAO, GUANGHUA · 2021 to 2024
$1.6M
Informatics Tools To Analyze And Model Whole Slide Image Data At The Single Cell LevelU01CA249245 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI XIAO, GUANGHUA · 2021 to 2023
$1.5M
Developing novel algorithms for spatial molecular profiling technologiesR01GM141519 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI XIAO, GUANGHUA · 2021 to 2024
$1.4M
Antibiotic Resistance Determination Utilizing Machine LearningU01AI169298 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GREENBERG, DAVID ELIHU, ZHAN, XIAOWEI · 2022 to 2024
$1.4M
Integrative Analysis to Identify Regulation Targets of RNA-Binding ProteinsR01GM115473 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI XIE, YANG · 2016 to 2019
$1.3M
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA142543NCI NIH HHS P50 CA070907NCI NIH HHS U01 CA249245NIAID NIH HHS U01 AI169298NIDCR NIH HHS R01 DE030656NIGMS NIH HHS R01 GM115473NIGMS NIH HHS R01 GM140012NIGMS NIH HHS R01 GM141519NIGMS NIH HHS R35 GM136375
6 · The paper itself

Abstract

Recent advancements in tissue imaging techniques have facilitated the visualization and identification of various cell types within physiological and pathological contexts. Despite the emergence of cell-cell interaction studies, there is a lack of methods for evaluating individual spatial interactions. In this study, we introduce Ceograph, a cell spatial organization-based graph convolutional network designed to analyze cell spatial organization (for example,. the cell spatial distribution, morphology, proximity, and interactions) derived from pathology images. Ceograph identifies key cell spatial organization features by accurately predicting their influence on patient clinical outcomes. In patients with oral potentially malignant disorders, our model highlights reduced structural concordance and increased closeness in epithelial substrata as driving features for an elevated risk of malignant transformation. In lung cancer patients, Ceograph detects elongated tumor nuclei and diminished stroma-stroma closeness as biomarkers for insensitivity to EGFR tyrosine kinase inhibitors. With its potential to predict various clinical outcomes, Ceograph offers a deeper understanding of biological processes and supports the development of personalized therapeutic strategies.

Indexed as

Deep LearningLung NeoplasmsCell CommunicationCell NucleusHumans

Identifiers

PMID38081823
PMCPMC10713592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.